Literature DB >> 26404825

Somatic mutation in cancer and normal cells.

Iñigo Martincorena1, Peter J Campbell2.   

Abstract

Spontaneously occurring mutations accumulate in somatic cells throughout a person's lifetime. The majority of these mutations do not have a noticeable effect, but some can alter key cellular functions. Early somatic mutations can cause developmental disorders, whereas the progressive accumulation of mutations throughout life can lead to cancer and contribute to aging. Genome sequencing has revolutionized our understanding of somatic mutation in cancer, providing a detailed view of the mutational processes and genes that drive cancer. Yet, fundamental gaps remain in our knowledge of how normal cells evolve into cancer cells. We briefly summarize a number of the lessons learned over 5 years of cancer genome sequencing and discuss their implications for our understanding of cancer progression and aging.
Copyright © 2015, American Association for the Advancement of Science.

Entities:  

Mesh:

Year:  2015        PMID: 26404825     DOI: 10.1126/science.aab4082

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  363 in total

1.  Deep sequencing as a probe of normal stem cell fate and preneoplasia in human epidermis.

Authors:  Benjamin D Simons
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-22       Impact factor: 11.205

Review 2.  Detecting Somatic Mutations in Normal Cells.

Authors:  Yanmei Dou; Heather D Gold; Lovelace J Luquette; Peter J Park
Journal:  Trends Genet       Date:  2018-05-03       Impact factor: 11.639

3.  Genome variation across cancers scales with tissue stiffness - an invasion-mutation mechanism and implications for immune cell infiltration.

Authors:  Charlotte R Pfeifer; Cory M Alvey; Jerome Irianto; Dennis E Discher
Journal:  Curr Opin Syst Biol       Date:  2017-04-27

Review 4.  Precancer in ulcerative colitis: the role of the field effect and its clinical implications.

Authors:  Kathryn T Baker; Jesse J Salk; Teresa A Brentnall; Rosa Ana Risques
Journal:  Carcinogenesis       Date:  2018-01-12       Impact factor: 4.944

Review 5.  Integrative Pharmacology: Advancing Development of Effective Immunotherapies.

Authors:  Mohammad Tabrizi; Daping Zhang; Vaishnavi Ganti; Glareh Azadi
Journal:  AAPS J       Date:  2018-04-27       Impact factor: 4.009

6.  Endogenous network states predict gain or loss of functions for genetic mutations in hepatocellular carcinoma.

Authors:  Gaowei Wang; Hang Su; Helin Yu; Ruoshi Yuan; Xiaomei Zhu; Ping Ao
Journal:  J R Soc Interface       Date:  2016-02       Impact factor: 4.118

Review 7.  Environmental influences on RNA processing: Biochemical, molecular and genetic regulators of cellular response.

Authors:  Athma A Pai; Francesca Luca
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-09-14       Impact factor: 9.957

8.  The Augmented R-Loop Is a Unifying Mechanism for Myelodysplastic Syndromes Induced by High-Risk Splicing Factor Mutations.

Authors:  Liang Chen; Jia-Yu Chen; Yi-Jou Huang; Ying Gu; Jinsong Qiu; Hao Qian; Changwei Shao; Xuan Zhang; Jing Hu; Hairi Li; Shunmin He; Yu Zhou; Omar Abdel-Wahab; Dong-Er Zhang; Xiang-Dong Fu
Journal:  Mol Cell       Date:  2018-01-27       Impact factor: 17.970

9.  Sample-specific perturbation of gene interactions identifies breast cancer subtypes.

Authors:  Yuanyuan Chen; Yu Gu; Zixi Hu; Xiao Sun
Journal:  Brief Bioinform       Date:  2021-07-20       Impact factor: 11.622

Review 10.  Improving Cancer Detection and Treatment with Liquid Biopsies and ptDNA.

Authors:  Michael D Kessler; Nisha R Pawar; Stuart S Martin; Toni M Antalis; Timothy D O'Connor
Journal:  Trends Cancer       Date:  2018-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.